Back To Search Instructions
Protocols
6 protocols meet the specified criteria
Disease Site: Rectum
Protocol No.TitleStatus
0200000785Core: A Tissue Resource (SPORE in GI Cancer)Open
1300000431N1048(PROSPECT**): A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision ** Pre-operative Radiation Or Selective Preoperative radiation and Evaluation before Chemotherapy and TMEOpen
1502660379S1316: Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
1502693695E7208: A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing ChemotherapyOpen
1503766405A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine TumorsOpen
1503768232S1406: Randomized Phase 11 Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer.Open